文献速递膀胱癌与上尿路尿路上皮癌

国际膀胱癌工作组中危非肌层浸润性膀胱癌评分系统可预测主动监测患者的结局

International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance.
PubMed 文献 · J Urol · 2023-08-03

前瞻性研究纳入163例低级别Ta/T1非肌层浸润性膀胱癌患者接受主动监测,中位随访33个月(IQR:21-46)后109例接受经尿道膀胱肿瘤电切术。24个月时0个危险因素者继续主动监测的可能性是≥3个危险因素者的2倍以上(59% vs 24%)。多因素Cox回归显示国际膀胱癌工作组中危非肌层浸润性膀胱癌评分系统与后续经尿道膀胱肿瘤电切术相关(1-2个危险因素HR:1.66,95%CI:0.96-2.90,P=.072;≥3个危险因素HR:3.21,95%CI:1.70-6.09,P<.001)。

要点

  • 24个月时0个危险因素者继续主动监测比例为59%,≥3个危险因素者为24%。
  • ≥3个危险因素者后续经尿道膀胱肿瘤电切术风险HR为3.21(95%CI:1.70-6.09,P<.001)。
  • 1-2个危险因素者HR为1.66(95%CI:0.96-2.90,P=.072),未达统计学显著。

核心结论

  • 国际膀胱癌工作组中危非肌层浸润性膀胱癌评分系统可预测接受主动监测的低级别非肌层浸润性膀胱癌患者后续经尿道膀胱肿瘤电切术的风险。

研究设计与样本

  • 前瞻性研究纳入163例接受主动监测的复发性低级别Ta/T1非肌层浸润性膀胱癌患者,纳入标准为低级别乳头状非肌层浸润性膀胱癌、≤5个外观低级别非肌层浸润性膀胱肿瘤、肿瘤直径≤1 cm、无肉眼血尿、尿细胞学阴性。
  • 对不再符合纳入标准或患者选择的患者行后续经尿道膀胱肿瘤电切术,采用多因素Cox比例风险分析确定与后续经尿道膀胱肿瘤电切术相关的因素。

主要发现

  • 中位随访33个月(IQR:21-46)后,109例患者接受了经尿道膀胱肿瘤电切术。
  • 24个月界标时间点,0个危险因素患者继续主动监测的可能性是≥3个危险因素患者的2倍以上(59% vs 24%)。
  • 多因素Cox回归校正年龄、T分期和性别后,国际膀胱癌工作组中危非肌层浸润性膀胱癌评分系统与后续经尿道膀胱肿瘤电切术相关:1-2个危险因素HR:1.66(95%CI:0.96-2.90,P=.072),≥3个危险因素HR:3.21(95%CI:1.70-6.09,P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to determine if the International Bladder Cancer Group IR-NMIBC (Intermediate-risk Nonmuscle-invasive Bladder Cancer) scoring system can predict the requirement of delayed transurethral resection of bladder tumor in low-grade nonmuscle-invasive bladder cancer managed by active surveillance. MATERIALS AND METHODS: We prospectively studied recurrent low-grade Ta/T1 nonmuscle-invasive bladder cancer patients managed with active surveillance with the following characteristics: low-grade papillary nonmuscle-invasive bladder cancer, ≤5 apparent low-grade nonmuscle-invasive bladder tumors, tumor diameter ≤1 cm, absence of gross hematuria, and negative urinary cytology. Subsequent transurethral resection of bladder tumor was offered to patients who no longer met the inclusion criteria or patient choice. The ability of the International Bladder Cancer Group IR-NMIBC scoring system to predict receipt of subsequent transurethral resection of bladder tumor was determined. Multivariable Cox proportional hazards analysis was used to determine factors associated with subsequent transurethral resection of bladder tumor. RESULTS: A total of 163 patients with low-grade Ta/T1 nonmuscle-invasive bladder cancer were included for analysis. After a median follow-up of 33 months (IQR: 21-46), transurethral resection of bladder tumor was performed on 109 patients. At landmark time point of 24 months, patients with 0 risk factors were over 2-fold more likely to continue active surveillance compared to patients with ≥3 risk factors (59% vs 24%). Multivariable Cox regression suggested that the International Bladder Cancer Group IR-NMIBC scoring system was associated with subsequent transurethral resection of bladder tumor (1-2 risk factors [HR: 1.66, 95% CI: 0.96-2.90, P = .072], ≥3 risk factors [HR: 3.21, 95% CI: 1.70-6.09, P < .001]) after adjusting for age, T stage, and sex. CONCLUSIONS: The International Bladder Cancer Group IR-NMIBC scoring system can predict the risk of subsequent transurethral resection of bladder tumor in patients with low-grade nonmuscle-invasive bladder cancer on active surveillance.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Tan WS, Contieri R, Buffi NM, et al. International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance. J Urol. 2023. PMID: 37535836. doi:10.1097/JU.0000000000003639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。